Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/1684Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Zhuravlyova, Larysa | - |
| dc.contributor.author | Lopina, Nataliia | - |
| dc.date.accessioned | 2012-11-22T08:31:59Z | - |
| dc.date.available | 2012-11-22T08:31:59Z | - |
| dc.date.issued | 2012 | - |
| dc.identifier.citation | Zhuravlyova L. Reducing Residual Vascular Risk Through combination Therapy with Fenofibrate and Alpha-Lipoic Acid in Patients with Ischemic Heart Disease and Type 2 Diabetes Mellitus : Abstracts from 15th International & 14th European Congress of Endocrinology, Florence, Italy, 5–9 May, 2012 / L. Zhuravlova, N. Lopina // Endocrine Abstracts. – 2012. – Vol. 29. – P. 713. | uk_UK |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/1684 | - |
| dc.description.abstract | To investigate effects of combination therapy with fenofibrate and α-lipoic acid on atherogenic dyslipidemia, which determines the residual vascular risk and endothelial dysfunction, levels of proinflammatory mediators in patients with ischemic heart disease and type 2 diabetes mellitus. | uk_UK |
| dc.language.iso | en | uk_UK |
| dc.subject | residual vascular risk | uk_UK |
| dc.subject | fenofibrate | uk_UK |
| dc.subject | alpha-lipoic acid | uk_UK |
| dc.subject | ischemic heart disease | uk_UK |
| dc.subject | type 2 diabetes mellitus | uk_UK |
| dc.title | Reducing Residual Vascular Risk Through combination Therapy with Fenofibrate and Alpha-Lipoic Acid in Patients with Ischemic Heart Disease and Type 2 Diabetes Mellitus | uk_UK |
| dc.type | Article | uk_UK |
| Appears in Collections: | Наукові праці. Кафедра внутрішньої медицини № 3 та ендокринології | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Reducing.pdf | 77,18 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.